http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#Head
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#assertion
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#provenance
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#pubinfo
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#assertion
http://purl.obolibrary.org/obo/DOID_0050782
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_0050782
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01129
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
http://www.w3.org/2000/01/rdf-schema#label
rabeprazole sodium delayed release tablets is a proton pump inhibitor ppi indicated in adults for healing of erosive or ulcerative gastroesophageal reflux disease gerd 1 1 maintenance of healing of erosive or ulcerative gerd 1 2 treatment of symptomatic gerd 1 3 healing of duodenal ulcers 1 4 helicobacter pylori 1 5 treatment of pathological hypersecretory conditions including zollinger ellison syndrome 1 6 in adolescent patients 12 years of age and older for short term treatment of symptomatic gerd 1 7 rabeprazole sodium delayed release tablets is indicated for short term 4 to 8 weeks treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease gerd for those patients who have not healed after 8 weeks of treatment an additional 8 week course of rabeprazole sodium delayed release tablets may be considered rabeprazole sodium delayed release tablets is indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease gerd maintenance controlled studies do not extend beyond 12 months rabeprazole sodium delayed release tablets is indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with gerd in adults for up to 4 weeks rabeprazole sodium delayed release tablets is indicated for short term up to four weeks treatment in the healing and symptomatic relief of duodenal ulcers most patients heal within four weeks rabeprazole sodium delayed release tablets in combination with amoxicillin and clarithromycin as a three drug regimen is indicated for the treatment of patients with h pylori h pylori h pylori see clinical studies 14 5 dosage and administration 2 5 in patients who fail therapy susceptibility testing should be done if resistance to clarithromycin is demonstrated or susceptibility testing is not possible alternative antimicrobial therapy should be instituted see clinical pharmacology 12 2 clinical pharmacology 12 2 rabeprazole sodium delayed release tablets is indicated for the long term treatment of pathological hypersecretory conditions including zollinger ellison syndrome rabeprazole sodium delayed release tablets is indicated for the treatment of symptomatic gerd in adolescents 12 years of age and above for up to 8 weeks
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01129
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#provenance
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#pubinfo
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig
http://purl.org/nanopub/x/hasSignature
T8ClaH8qWhimQpqdlB5YtASDX/HKAHhSWrjpB3R+aja7aSqox08fSaFi9HrLHgHaV6vaN71TIptkBAIaGZWhG48PiaVFyjUSzoJzGrfE0pUF0D7dvuUC2hNUauEyPrE+kuICAslaZJ6Oq0QpxhZ+oH0Ep9wEgQcXtRE1n/vwlQg=
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
http://purl.org/dc/terms/created
2021-06-13T15:14:34.455+02:00
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAmo2cySsNgjH_n79Soy4SWLUzysC2unVwMf3WAwHEIRU
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs